Marlene Scardamalia’s theoretical, pedagogical and technological innovations have helped to create and shape a new field of inquiry: Knowledge Building. Knowledge Building engages students directly in the means by which knowledge in the world is advanced. Scardamalia’s award-winning research and development spanning a global network of hubs of innovation is making knowledge creation, previously reserved for a few, central to education for all students at all levels.

Marlene Scardamalia et ses innovations théoriques, pédagogiques et technologiques ont contribué à créer et à façonner un nouveau champ d’investigation : la construction du savoir. La construction du savoir engage directement les étudiants dans les moyens d’avancement des connaissances dans le monde. La recherche et le développement primés de Scardamalia, qui couvrent un réseau mondial de centres d’innovation, font de la création de connaissances, auparavant réservée à quelques-uns, un élément central de l’éducation pour les étudiants de tous les niveaux.

Dr. Schachter's major concern has been the biological synthesis, by enzymes (glycosyltransferases), of complex carbohydrates, important and unique components of all cell surfaces. He is a major figure in the field, through his research, his guidance of graduate students, and his lectures and written reviews. He was a pioneer with many unique contributions, including the first to localize these enzymes in the Golgi apparatus, thereby pointing to its important role in glycosylation, and the first to systematically isolate and characterize key glycosyltransferases (ten of them) involved in glycan branching and core synthesis, and to delineate the rules which control the synthesis of these highly complex structures. The biochemistry and molecular biology of these enzymes has since become a major field of study by his laboratory and others interested in the functions of complex carbohydrates and in the development of new therapeutic approaches to cancer metastasis, inflammation and other areas of medicine.

SCHAFER, Laurel - Department of Chemistry, The University of British Columbia Prof. Laurel Schafer has made seminal research contributions bridging the areas of organometallic and organic chemistry; she has developed a versatile ground-breaking new class of early transition metal complexes for use in selective carbon-nitrogen and carbon-carbon bond forming reactions of industrial relevance. These new catalytic systems synergistically minimise waste and maximise energy efficiency by utilising metals of low toxicity for sustainable approaches towards selective and specific chemical transformations.

John Scheffer has attained worldwide recognition for his pioneering research in the field of solid-state organic chemistry. Scheffer is the author of over 200 research publications and the recipient of a number of fellowships and awards, most recently the 2000 Alfred Bader Lecture Award of the Canadian Society for Chemistry.

Long Citation Stephen Scherer is one of Canada's leading geneticists making seminal contributions to the understanding of the human genome. He is internationally known for contributions to decoding the sequence of human chromosome 7, including the identification of 20 disease causing genes. His group also discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. He has published over 650 publications, won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada. Short Citation Stephen Scherer is an internationally known geneticists making seminal contributions to the understanding of the human genome. His group discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. Dr. Scherer has won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada.

Dr. Schiller is a world leader in peptide chemistry. He has developed new concepts in receptor-selective opioid analogs on the basis of the so-called membrane compartment concept. One of them, carrying a high positive charge, displayed unprecedented µ-selectivity is by far the most selective µ-agonist known to date and appears to have considerable potential for clinical applications. In 1987, he received the Max-Bergmann Medal which is one of the highest recognition in peptide research. He received the Galen Award (Prix Galien) for excellence in pharmaceutical research (1995), an NIH Merit Award (1997) and the Vincent du Vigneaud Award of the American Peptide Society (1998). He was elected a Fellow of The American Association of Pharmaceutical Sicentists in 1998. In 1999, he was appointed "officier" of the Ordre national du Québec".

Dr. Aaron Schimmer is an international authority in cancer research focused on blood cancers known as leukemia. Through multiple pioneering discoveries, he has demonstrated how mitochondrial and metabolic pathways influence the development and progression of acute myeloid leukemia. As a clinician-scientist, he has translated these breakthroughs into the clinic by launching early phase clinical trials to evaluate new treatments for the disease.

Aaron Schimmer est une sommité internationale dans le domaine de la recherche sur les cancers sanguins, connus sous le nom de leucémies. Grâce à de nombreuses découvertes pionnières, il a démontré l’influence des voies mitochondriales et métaboliques sur le développement et la progression de la leucémie myéloïde aiguë. En tant que clinicien-scientifique, il a lancé des essais cliniques de phase précoce pour évaluer de nouveaux traitements de la maladie.

SCHLICH, Thomas – Social Studies of Medicine, McGill University Thomas Schlich is an eminent scholar in the history of modern surgery. His research has examined the rationale for surgery—why surgeons open the body—and the techniques they developed to do so—how they do it. Schlich’s work thus elucidates the history of medical innovation in its scientific, intellectual and social context, including organ transplants, metal implants in fracture treatment and minimally invasive surgery.

Thomas Schlich est un éminent chercheur en histoire de la chirurgie moderne. Ses recherches portent sur la logique de la chirurgie – les raisons pour lesquelles les chirurgiens ouvrent le corps – et sur les techniques développées à cette fin – les manières dont ils le font. Ses travaux éclairent ainsi l’histoire de l’innovation médicale dans ses contextes scientifique, intellectuel et social, y compris les transplantations d’organes, les implants métalliques dans le traitement des fractures et la chirurgie non effractive.

SCHMIDT, Bonnie - Department of Science, Engineering, Social Sciences, Health Sciences, Western University Bonnie Schmidt, the founder of “Let’s Talk Science”, is a pioneer in science education for Canadian school children and teachers. Due to Bonnie’s drive and exceptional dedication, the initiative she started as a graduate student over 20 years ago is now a multi-dimensional national programme, providing over six million Canadian children, regardless of gender, race or social standing, the opportunity to develop their skills in problem solving and critical thinking.

Bonnie Schmidt, fondatrice de Parlons sciences, est une pionnière au chapitre de la formation scientifique s’adressant aux enfants, aux adolescents et aux enseignants d’un bout à l’autre du pays. Grâce à son dynamisme et à son dévouement, l’initiative qu’elle a lancée alors qu’elle terminait ses études universitaires il y a plus de 25 ans s’est transformée en un organisme de bienfaisance d’envergure nationale qui a déjà touché près de sept millions de Canadiens. Parlons sciences suscite l’intérêt de tous les jeunes indépendamment de leur sexe, de leurs antécédents culturels ou de leur situation géographique, les aidant à développer les compétences et les attitudes dont ils auront besoin pour répondre aux exigences professionnelles et citoyennes d’un monde en rapide évolution.

SCHOFIELD, Stephen – Arts visuels et médiatiques, Université du Québec à Montréal Professor and renowned artist for the variety and the quality of his practice namely in sculptures, Stephen Schofield has lead an exceptional career for over thirty years in Canada and abroad. Considered as one the most important artists who have transformed Canadian contemporary sculpture, his works are exhibited in the most famous museums, galleries and artist centres in Canada.

SCHOFIELD, Stephen – Arts visuels et médiatiques, Université du Québec à Montréal Professeur et artiste reconnu pour la richesse et la variété de sa pratique, notamment en sculpture, Stephen Schofield mène une carrière remarquable depuis trente ans au Canada et à l’étranger, notamment à New York et Paris. Considéré comme l’un des artistes canadiens ayant le plus transformé le paysage de la sculpture contemporaine au Canada, ses oeuvres sont exposées dans les plus importants musées, galeries et centres artistiques au pays.

Gary John Schrobilgen, Department of Chemistry, McMaster University, has made important contributions in two major areas of main-group inorganic chemistry: fluorine chemistry and the polyatomic anions of the main-group elements. He is best known for his outstanding contributions to the experimentally challenging field of fluorine chemistry, encompassing the syntheses and structural characterization of a significant number of the known compounds of the noble gases as well as fluoro- and oxofluoro-derivatives of the main-group and transition elements in their highest oxidation states and at the limits of coordination. He is particularly known for the syntheses of new xenon-nitrogen bonds and for the first krypton-nitrogen and krypton-oxygen bonds and for his application of multi-nuclear magnetic resonance (NMR) and Raman spectroscopy and X-ray crystallography to the elucidation of the structures of highly unstable compounds. His work has been of importance in our understanding of structure and chemical bonding in so-called "hypervalent" molecules and in main-group ring, cage and cluster molecules.